These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1177612)

  • 1. [Which factors should influence the choice of drugs?].
    Lakartidningen; 1975 Oct; 72(40):3828-34. PubMed ID: 1177612
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physician's choice of preparations].
    Lilja J
    Lakartidningen; 1975 Sep; 72(39):3626-7. PubMed ID: 1177588
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of drugs is a bigger problem than the choice of drugs].
    Rosén A
    Lakartidningen; 1975 Sep; 72(39):3627-8. PubMed ID: 1177589
    [No Abstract]   [Full Text] [Related]  

  • 4. [Selection and evaluation of drugs].
    Nybäck H
    Lakartidningen; 1975 Sep; 72(39):3628-9. PubMed ID: 1177590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Towards a new drug management].
    Hoffmann M; Ahlner J
    Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634
    [No Abstract]   [Full Text] [Related]  

  • 6. [The place of drugs in health economics].
    Sigvard J
    Therapie; 1977; 32(5):529-52. PubMed ID: 349766
    [No Abstract]   [Full Text] [Related]  

  • 7. [Production, control and consumption of drugs in Mexico (preliminary report)].
    Heredia Duarte A
    Salud Publica Mex; 1975; 17(2):169-80. PubMed ID: 1198248
    [No Abstract]   [Full Text] [Related]  

  • 8. What action for rational drug use?
    Khan I
    World Health Forum; 1997; 18(1):83-6. PubMed ID: 9233081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drugs].
    Greppin R
    Z Krankenpfl; 1972 Dec; 65(12):446-51. PubMed ID: 4486551
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorials: The FDA--reprise.
    Thomison JB
    J Tenn Med Assoc; 1973 Nov; 66(11):1071-2. PubMed ID: 4756263
    [No Abstract]   [Full Text] [Related]  

  • 11. [Criteria for choice of preparations in a drug committee].
    Lunde PK
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):37-40. PubMed ID: 1111161
    [No Abstract]   [Full Text] [Related]  

  • 12. Health authorities and drug utilization studies.
    Garcia Alonso F; Scott AI; Stika L; Westerholm B
    WHO Reg Publ Eur Ser; 1993; 45():147-67. PubMed ID: 8442843
    [No Abstract]   [Full Text] [Related]  

  • 13. Partnership in health.
    Burrell CD
    N Z Med J; 1981 Jan; 93(675):12-4. PubMed ID: 6937798
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased support for drug evaluation].
    Lakartidningen; 1969 Jan; 66(4):322-3. PubMed ID: 5818700
    [No Abstract]   [Full Text] [Related]  

  • 15. [European drug market--dream or nightmare?].
    Nord Med; 1974 Jan; 89(1):6-8. PubMed ID: 4819431
    [No Abstract]   [Full Text] [Related]  

  • 16. [The sale of psychoactive drugs and hypnotics in Sweden and Norway--based on dosage statistics].
    Halse M; Halvorsen IK; Lunde PK
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2595-7. PubMed ID: 4149291
    [No Abstract]   [Full Text] [Related]  

  • 17. Keeping prescription drugs safe and effective.
    Bryan PA
    Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
    [No Abstract]   [Full Text] [Related]  

  • 18. Special section. The evaluation of drugs: an international perspective.
    Int J Technol Assess Health Care; 1986; 2(4):613-708. PubMed ID: 10280881
    [No Abstract]   [Full Text] [Related]  

  • 19. [The length of time a drug patent is effective must be prolonged].
    Hertzman P
    Lakartidningen; 1989 Apr; 86(15):1338, 1343. PubMed ID: 2716442
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of therapeutic equivalence in drug registration and control.
    Idänpään-Heikkilä J
    Ann Clin Res; 1974; 6(0):suppl 11:71-8. PubMed ID: 4850672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.